{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T11:56:18Z","timestamp":1768478178896,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T00:00:00Z","timestamp":1363132800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>One of the major issues in clinical practice is the accurate differential diagnosis between mixed states and depression, often leading to inappropriate prescriptions of antidepressants in mixed states, and as a consequence, increasing the risk of manic switch and suicide. In order to better define the spectrum of mixed states, it may be useful to develop a dimensional approach. In this context, the MAThyS (Multidimensional Assessment of Thymic States) scale was built to assess activation\/inhibition levels in all bipolar mood episodes, and to determine whether a clinical description in terms of activation\/inhibition can help better define bipolar states with which both manic and depressive symptoms are associated. The aim of this paper is the validation of the MAThyS scale in 141 bipolar patients in acute states (manic, hypomanic, mixed, or depressive).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The validation of the MAThyS scale was the primary outcome of this 24-week, phase III, open-label, olanzapine single-arm clinical trial. Principal component, factorial analysis, and Cronbach\u2019s coefficient calculation (internal consistency) were performed. Concurrent validity (correlations with 17-item Hamilton Depression Rating Scale [HAMD-17], Hamilton Anxiety Rating Scale [HAMA], and Young Mania Rating Scale [YMRS]) and responsiveness to the clinical intervention were assessed (change in MAThyS scale and effect size) at 6 and 24\u00a0weeks.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Scree plot of eigenvalues identified a 2-dimension structure (\u201cactivation\/inhibition level\u201d and \u201cemotional component\u201d). Psychometric properties were good: Cronbach\u2019s coefficient was &gt;0.9. Concurrent validity was good with low correlation (\u22120.19) with the HAMA scale and a higher correlation at baseline with the YMRS (0.72) and HAMD-17(\u22120.43). As expected, the activation state was predominant in manic, hypomanic, and mixed states while inhibition was predominant in depressive states. MAThyS score improvement was observed (effect size: -0.3 at 6 and 24\u00a0weeks).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The MAThyS demonstrated good psychometric properties. The MAThyS scale may help clinicians to better discriminate and follow bipolar episodes, especially the broad spectrum of mixed episodes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov registration identification number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00259272?term=S057&amp;rank=2\" ext-link-type=\"uri\">NCT#002592722<\/jats:ext-link>\n            <\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-244x-13-79","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T05:54:14Z","timestamp":1363154054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Inhibition\/activation in bipolar disorder: validation of the Multidimensional Assessment of Thymic States scale (MAThyS)"],"prefix":"10.1186","volume":"13","author":[{"given":"Chantal","family":"Henry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amandine","family":"Luquiens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Lan\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Sapin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Zins-Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Gerard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Falissard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Lukasiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jad.2005.01.005","volume":"96","author":"EG Hantouche","year":"2006","unstructured":"Hantouche EG, Akiskal HS, Azorin JM, Ch\u00e2tenet-Duch\u00eane L, Lancrenon S: Clinical and psychometric characterization of depression in mixed mania: a report from the french national cohort of 1090 manic patients. J Affect Disord. 2006, 96: 225-232. 10.1016\/j.jad.2005.01.005.","journal-title":"J Affect Disord"},{"key":"1252_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eurpsy.2003.09.008","volume":"19","author":"F Benazzi","year":"2004","unstructured":"Benazzi F, Koukopoulos A, Akiskal HS: Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry. 2004, 19: 85-90. 10.1016\/j.eurpsy.2003.09.008.","journal-title":"Eur Psychiatry"},{"key":"1252_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1176\/appi.ajp.161.1.163","volume":"161","author":"SN Ghaemi","year":"2004","unstructured":"Ghaemi SN, Rosenquist KJ, Ko JY, Baldassano CF, Kontos NJ, Baldessarini RJ: Antidepressant treatment in bipolar versus unipolar depression. Am J Psychiatry. 2004, 161: 163-165. 10.1176\/appi.ajp.161.1.163.","journal-title":"Am J Psychiatry"},{"key":"1252_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jad.2006.04.003","volume":"94","author":"Z Rihmer","year":"2006","unstructured":"Rihmer Z, Akiskal H: Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord. 2006, 94: 3-13. 10.1016\/j.jad.2006.04.003.","journal-title":"J Affect Disord"},{"key":"1252_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-244X-8-82","volume":"8","author":"C Henry","year":"2008","unstructured":"Henry C, M\u2019Bailara K, Mathieu F, Poinsot R, Falissard B: Construction and validation of a dimensional scale exploring mood disorders: MAThyS (Multidimensional Assessment of Thymic States). BMC Psychiatry. 2008, 8: 82-10.1186\/1471-244X-8-82.","journal-title":"BMC Psychiatry"},{"key":"1252_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000107559","volume":"76","author":"C Henry","year":"2007","unstructured":"Henry C, M\u2019Ba\u00eflara K, Poinsot R, Casteret AA, Sorbara F, Leboyer M, Vieta E: Evidence for two types of bipolar depression using a dimensional approach. Psychother Psychosom. 2007, 76: 325-331. 10.1159\/000107559.","journal-title":"Psychother Psychosom"},{"key":"1252_CR7","volume-title":"Activation\/Inhibition Response, Efficacy, Safety of Olanzapine in Acute Bipolar Patient: Secondary Outcomes of a 24-Weeks Open-Label Single-Arm Trial","author":"C Henry","year":"2010","unstructured":"Henry C, Luquiens A, Lan\u00e7on C: Activation\/Inhibition Response, Efficacy, Safety of Olanzapine in Acute Bipolar Patient: Secondary Outcomes of a 24-Weeks Open-Label Single-Arm Trial. 2010, New Orleans, LA: 163rd APA annual meeting, Abstract NR1-49"},{"key":"1252_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0165-0327(01)00441-4","volume":"67","author":"HS Akiskal","year":"2001","unstructured":"Akiskal HS, Hantouche EG, Bourgeois ML, Azorin JM, Sechter D, Allilaire JF, Chaten\u00eat-Duch\u00eane L, Lancrenon S: Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J Affect Disord. 2001, 67: 89-96. 10.1016\/S0165-0327(01)00441-4.","journal-title":"J Affect Disord"},{"issue":"Issue 1, Supple","key":"1252_CR9","first-page":"56","volume":"36","author":"C Henry","year":"2010","unstructured":"Henry C, Luquiens A, Lan\u00e7on C: Validation de l\u2019\u00e9chelle \u201cMultidimensional assessment of THYmic states\u201d (Etude MAThyS). LEnc\u00e9phale. 2010, 36 (Issue 1, Supplement 1): 56-57.","journal-title":"LEnc\u00e9phale"},{"key":"1252_CR10","volume-title":"Quality of Life Assessment in Clinical Trials: Methods and Practice","author":"MJ Staquet","year":"1998","unstructured":"Staquet MJ, Hays RD, Fayers PM: Quality of Life Assessment in Clinical Trials: Methods and Practice. 1998, New York: Oxford University Press"},{"key":"1252_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter TA, Sachs G, Bowden C, Mitchell PB, Centorrino F, Risser R, Baker RW, Evans AR, Beymer K, Dube S, Tollefson GD, Breier A: Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003, 60: 1079-1088. 10.1001\/archpsyc.60.11.1079.","journal-title":"Arch Gen Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-13-79\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-13-79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:41:10Z","timestamp":1630536070000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-13-79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-13-79","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,13]]},"assertion":[{"value":"29 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"79"}}